Aerodynamic particle size distribution by cascade impaction

Quantitative determination of active ingredient fractioned by NGI for routine analysis, method development and validation/transfer work

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP